PTC Therapeutics Announces Validation of Sepiapterin European MAA

Go back to PTC Therapeutics Announces Validation of Sepiapterin European MAA
PTC THERAPEUTICS (NASDAQ: PTCT) Delayed: 63.46 -0.67 (1.04%)
Previous Close $64.13    52 Week High $35.40 
Open $64.81    52 Week Low $4.03 
Day High $65.40    P/E 6.75 
Day Low $62.80    EPS $9.40 
Volume 901,785